1. Home
  2. FRMI vs LGND Comparison

FRMI vs LGND Comparison

Compare FRMI & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRMI

Fermi Inc.

HOLD

Current Price

$8.55

Market Cap

4.2B

Sector

Real Estate

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$263.12

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRMI
LGND
Founded
2025
1987
Country
United States
United States
Employees
35
68
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FRMI
LGND
Price
$8.55
$263.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$26.13
$256.29
AVG Volume (30 Days)
16.4M
172.7K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.25
Revenue Next Year
$120.76
$19.41
P/E Ratio
N/A
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$4.47
$111.72
52 Week High
$32.39
$259.03

Technical Indicators

Market Signals
Indicator
FRMI
LGND
Relative Strength Index (RSI) 72.04 75.66
Support Level $8.65 $199.97
Resistance Level $10.57 N/A
Average True Range (ATR) 0.67 7.59
MACD 0.22 2.31
Stochastic Oscillator 86.59 90.88

Price Performance

Historical Comparison
FRMI
LGND

About FRMI Fermi Inc.

Fermi Inc building a private power campus for AI-centric customers, developing and leasing large-scale, grid-independent energy generation and high-performance computing facilities purpose-built for the hyperscale era. The company is also developing a private energy and site infrastructure platform across the campus to support multiple powered shell buildings and a diversified, integrated power supply, including private power generation and delivery infrastructure, substations, internal distribution networks, water and cooling systems, and other essential infrastructure. In addition to powered shell facilities, it may offer long-term ground leases to tenants that elect to construct their own powered shell facilities on land, with or without integrated power delivery.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: